"Riverside Community Hospital, an affiliate of HCA Healthcare, is a full-service acute care hospital founded in 1901 in the heart of the Inland Empire. The facility has been recognized as a Top Performing Hospital with 478 licensed beds, over 700 physicians on staff, representing over 200 specialties and over 2,500 employees. Riverside Community Hospital is a leader in providing advanced, comprehensive health care to Southern California. It houses the largest Emergency Room and Level I Trauma Center in Riverside County at 62 beds, is one of the county’s only STEMI receiving centers, a fully accredited Chest Pain Center and an accredited Comprehensive Stroke Center."

During the past decade, Riverside Community Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Riverside Community Hospital" #1 sponsor was "Harvard Pilgrim Health Care" with 6 trials, followed by "Medtronic Vascular" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Balt USA" with 1 trials sponsored and "Duke University" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Riverside Community Hospital" #1 collaborator was "University of California, Irvine" with 6 trials as a collaborator, "University of Massachusetts, Amherst" with 6 trials as a collaborator, "Brigham and Women's Hospital" with 5 trials as a collaborator, "Centers for Disease Control and Prevention" with 4 trials as a collaborator and "Rush University" with 4 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Riverside Community Hospital" are "Coronary Artery Disease" (3 trials), "Abdominal (ABD) Infection" (1 trials), "COVID-19" (1 trials), "Cluster Detection" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Riverside Community Hospital" in a lesser frequency.

Most popular intervention types in "Riverside Community Hospital" are "Other" (7 trials), "Device" (4 trials), "Drug" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arm 1: Routine Care" (2 trials), "INSPIRE CPOE Smart Prompt" (2 trials), "Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System" (2 trials), "Routine Care" (2 trials) and "2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Riverside Community Hospital" are 13 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Riverside Community Hospital". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Riverside Community Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Riverside Community Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".